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Generally  regarded  as  extracellular  pathogens,  molecular  mechanisms  of  mycoplasma  persistence,
chronicity  and  disease  spread  are  largely  unknown.  Mycoplasma  agalactiae,  an  economically  important
pathogen  of  small  ruminants,  causes  chronic  infections  that  are  difﬁcult  to  eradicate.  Animals  continue
to  shed  the agent  for several  months  and  even  years  after  the initial  infection,  in spite of long  antibi-
otic  treatment.  However,  little  is  known  about  the strategies  that M. agalactiae  employs  to survive  and
spread  within  an immunocompetent  host  to cause  chronic  disease.  Here,  we  demonstrate  for  the ﬁrst
time  its ability  to invade  cultured  human  (HeLa)  and  ruminant  (BEND  and BLF)  host  cells.  Presence  of
intracellular  mycoplasmas  is  clearly  substantiated  using  differential  immunoﬂuorescence  technique  and
quantitative  gentamicin  invasion  assays.  Internalized  M.  agalactiae  could  survive  and  exit  the  cells  in  a
viable state  to repopulate  the  extracellular  environment  after complete  removal  of  extracellular  bacte-
ria  with  gentamicin.  Furthermore,  an  experimental  sheep  intramammary  infection  was  carried  out  to
evaluate  its systemic  spread  to organs  and  host  niches  distant  from  the  site  of initial  infection.  Positive
results  obtained  via  PCR,  culture  and  immunohistochemistry,  especially  the  latter  depicting  the  presence
of M. agalactiae  in the  cytoplasm  of  mammary  duct  epithelium  and  macrophages,  clearly  provide  the ﬁrst
formal  proof  of  M.  agalactiae’s  capability  to translocate  across  the  mammary  epithelium  and  systemically
disseminate  to distant  inner  organs.  Altogether,  the  ﬁndings  of these  in  vitro  and  in  vivo  studies  indicate
that  M. agalactiae  is capable  of entering  host  cells  and  this  might  be the  strategy  that it  employs  at  a
population  level  to  ward  off  the  host  immune  response  and  antibiotic  action,  and  to  disseminate  to  new
and  safer  niches  to  later  egress  and  once  again  proliferate  upon  the  return  of favorable  conditions  to
cause  persistent  chronic  infections.
© 2014  The  Authors.  Published  by  Elsevier  GmbH.  This  is  an open  access  article  under  the  CC  BYntroduction
Commonly described as the smallest and simplest bacteria,
ycoplasmas are important pathogens of humans and animals
ith rather complex and sophisticated pathogenic attributes
Rosengarten et al., 2000). Having lost many of their metabolic
athways during a so-called degenerative evolution from a Gram-
ositive ancestor, these wall-less prokaryotes readily obtain their
utrition from host cells by mostly colonizing epithelial surfaces
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and thereby cause slow-progressing chronic diseases that are dif-
ﬁcult to cure (Razin et al., 1998). Well-known for their antigenic
variation systems, they have adapted sophisticated mechanisms
to evade immune clearance, survive in the host and have evolved
to infect new host niches (Rottem and Barile, 1993; Chopra-
Dewasthaly et al., 2012; Citti and Blanchard, 2013). Mycoplasmas
lack typical bacterial virulence factors like toxins, and the molecu-
lar determinants of their pathogenicity are largely unknown. This
can be partially attributed to their fastidious and slow growth, rel-
ative recalcitrance to genetic manipulations, and also to their strict
host-speciﬁcity that hinders the development of convenient small
animal models (Razin et al., 1998; Citti and Blanchard, 2013).
Mycoplasma agalactiae is an economically important pathogen
and the main etiological agent of contagious agalactia (CA) syn-
drome in sheep and goats, mainly characterized by mastitis,
le under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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onjunctivitis and arthritis as predominant symptoms of a local-
zed infection. Sporadically septicaemia, arthritis, pneumonia and
eproductive disorders have also been reported (Bergonier et al.,
997; Gomez-Martin et al., 2013), indicating that the pathogen
s capable of crossing the epithelial barrier to reach distant host
iches, as also evidenced in a recent report where naturally infected
symptomatic male goats were shown to harbour M. agalactiae in
typical inner organs like brain and heart (Gomez-Martin et al.,
012). Nevertheless, M.  agalactiae has so far been regarded as an
xtracellular parasite and it is unknown how it transforms local
nfections into systemic ones.
Persistence and chronicity are other hallmarks of M. agalac-
iae infections. Both diseased and asymptomatic animals continue
o shed the pathogen for long periods of time, sometimes lasting
p to several years (Bergonier et al., 1997). Antibiotic treatments
re often unsuccessful as they can only reduce clinical symptoms
ut tend to promote the carriers that stay unaffected (Nicholas,
002). Chronically infected and serologically negative herds with
o signs of disease are a common clinical-epidemiological situa-
ion in endemic areas. Such animals easily escape disease control
nd eradication measures, and are capable of ﬂaring up frequent
A outbreaks under stress conditions (Gomez-Martin et al., 2013)
eading to huge economic losses. Despite such agronomical signiﬁ-
ance,  M.  agalactiae’s pathogenic determinants and mechanisms of
nfection and persistence are largely unknown, a fact that can be
ttributed to its long resistance to genetic manipulation until 2005
Chopra-Dewasthaly et al., 2005a, b), and also because it does not
xhibit the more practical phenotypes associated with mycoplasma
athogenicity, such as hemadsorption and the presence of terminal
ip structure as attachment organelle, and lacks convenient small
nimal models or cell lines for appropriate studies.
M. agalactiae demonstrates surface antigenic diversity via
igh-frequency switching of six immunodominant surface lipo-
roteins (Vpmas) caused by Xer1 recombinase encoded on the
ame pathogenicity island-like locus (Glew et al., 2002; Chopra-
ewasthaly et al., 2008; Czurda et al., 2010). Though lacking
n concrete proof, such variable systems are often believed to
lay important roles in pathogenicity via host immune evasion
nd adaptation. Our data from a recent experimental infection
tudy with Xer1-disrupted Vpma ‘phase-locked’  mutants (Chopra-
ewasthaly et al., 2008) clearly demonstrated that Xer1 is not a
irulence factor of M. agalactiae and Vpma phase variation is not
ecessary for establishing infection though it might critically inﬂu-
nce the survival and persistence of the pathogen under natural
eld conditions (Chopra-Dewasthaly et al., 2012). P40, a cytad-
esin, and P48 with macrophage stimulatory activity, are two other
ipoproteins, which seem to have important pathogenicity related
ttributes (Rosati et al., 1999; Fleury et al., 2002). Besides, produc-
ion of hydrogen peroxide (Khan et al., 2005), bioﬁlm formation
McAuliffe et al., 2006) and identiﬁcation of genes involved in
ndirect host cell interactions (Baranowski et al., 2010) are also
mplicated in M.  agalactiae’s pathogenicity.
In view of the prevailing scenario, we tried to investigate
hether M.  agalactiae has the capacity to enter, survive and exit
he eukaryotic host cells in a viable state, as this could explain the
hronic, persistent and difﬁcult-to-eradicate nature of its infec-
ions in spite of long antibiotic therapies. This phenomenon may
lso allow it to reach more favorable host niches by crossing the
pithelial barrier as cell invasion is often considered a major fac-
or for systemic spread (Cieri et al., 2002; Much et al., 2002). Here,
e provide evidence for the ﬁrst time that M.  agalactiae is able
o invade eukaryotic host cells whereby quantitative results are
upported by the qualitative double immunoﬂuorescence assay.
ntracellular mycoplasmas were detected not only after in vitro
nfection but also in vivo in various tissue samples from experi-
entally infected sheep using immunohistochemistry. Also, by theal Microbiology 304 (2014) 1024–1031 1025
isolation of mycoplasmas from various internal organs of sheep
experimentally infected via the intramammary route we formally
demonstrate that M.  agalactiae has the capability to cross local
epithelial barriers and to disseminate to distant body sites. The
ﬁndings of this study, together with the sophisticated antigenic
variation system, could explain the persistence and chronicity of
M. agalactiae infections.
Materials and methods
Mycoplasma growth
M. agalactiae pathogenic type strain PG2 (Sirand-Pugnet et al.,
2007) was used in this study and was  previously isolated from an
infected goat in Spain (Fleury et al., 2002). It was grown in Alu-
otto or SP4 medium supplemented with penicillin, pyruvate, and
phenol red as indicator as described before (Chopra-Dewasthaly
et al., 2005b). Mycoplasma cultures were grown for 48 h and diluted
serially in minimal essential medium (MEM)  supplemented with
non-essential amino acids and 10% heat inactivated fetal bovine
serum (FBS) (Gibco BRL, Life Technologies) prior to infection of cul-
tured mammalian cells. Number of viable mycoplasmas at the time
of infection was determined by plating serial dilutions on SP4 plates
containing 1% (wt/vol) Difco Noble agar and counting colonies
under BMS  74955 stereomicroscope after 4–5 days of incubation
at 37 ◦C.
Cell culture
HeLa-229 (ATCC CCL-2.1), Bovine endometrium cell line BEND
(ATCC CRL-2398) and Buffalo lung ﬁbroblasts (BLF; ATCC IMR-31)
were the cell lines used in this study and were purchased from
the American Type Culture Collection (ATCC; Manassas, USA) and
certiﬁed to be free of mycoplasmas. HeLa-229 was maintained in
MEM,  BLF in McCoy’s 5a medium (Sigma) with 10% heat inactivated
FBS, and BEND cells in 1:1 mixture of Hams F12 and Eagle’s  MEM
with Earle’s BSS (Sigma-Aldrich) as per the instructions of ATCC.
Trypsin and PBS were purchased from PAA Laboratories GmbH,
Pasching, Austria or Sigma-Aldrich. 1 × 104 cells/well were seeded
into Lab-Tek II Chamber Slides (Nunc International, Naperville,
IL) for immunoﬂuorescence staining and 5 × 104 cells/well were
seeded into 24-well plates (CELLSTAR® Greiner Bio-One GmbH,
Germany) for the gentamicin invasion assay 48 h prior to infec-
tion to attain conﬂuence. Cell cultures were regularly checked for
mycoplasma contamination by culture and PCR.
Mycoplasma infection and gentamicin invasion assay
Gentamicin invasion assay was  carried out as described before
with some modiﬁcations (Elsinghorst, 1994; Winner et al., 2000).
M. agalactiae was  grown for about 48 h indicated by metabolic color
change before pelleting at 10,000 × g at 4 ◦C for 10 min  and resus-
pending in MEM.  The cells were passed through 27-gauge needle
for three to four times to disrupt any cell aggregates. Eukaryotic
cells were infected with diluted cultures of mycoplasmas at a multi-
plicity of infection (MOI) of about 10–30 and incubated at 37 ◦C with
5% CO2 for 4, 8, 16 and 24 h. Thereafter, extracellular bacteria were
killed by incubation in MEM  containing 400 g/ml of gentamicin
for an additional 3 h period. Although a concentration of 50 g/ml
gentamicin is known to be completely inhibitory for M.  agalactiae
growth (Chopra-Dewasthaly et al., 2005b), a higher concentration
of 400 g/ml was used to ensure the reliability of the assay and was
experimentally determined to be sufﬁcient to kill 100% of M.  agalac-
tiae in 3 h duration. After gentamicin treatment, supernatants were
checked for the presence of any viable mycoplasmas by plating on
SP4 agar. Subsequently, the cells were washed two  to three times
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ith PBS and trypsinized before making serial dilutions for plat-
ng on SP4 agar to quantify invaded mycoplasmas. Trypsinization
id not cause any adverse effects on the mammalian cells as con-
rmed by the viable cell counts using trypan blue staining. Invasion
requency was calculated as percentage ratio of cfu of intracellular
ycoplasmas to cfu of mycoplasmas added initially. Survival and
xit of mycoplasmas from the eukaryotic cells was assessed by the
ame procedure as was described for invasion, except that after 24 h
f infection, eukaryotic cells were further incubated in fresh MEM
ontaining 50 g/ml gentamicin for 8, 16 and 24 h. This lower con-
entration of gentamicin was checked to be sufﬁcient to prevent the
ultiplication of mycoplasmas (Chopra-Dewasthaly et al., 2005b).
scape of invaded intracellular mycoplasmas from eukaryotic cells
nd their reinfection was monitored by incubating the cells in par-
llel wells under the same conditions in absence of gentamicin.
enicillin (50 g/ml) was added here as a control antibiotic to pre-
ent general contamination. Cells collected at 8, 16 and 24 h post
entamicin treatment were then serially diluted and plated on SP4
gar. The cfu obtained in presence and in absence of gentamicin
ere compared with the cfu of invaded mycoplasmas at 24 h pi.
iability of eukaryotic cells was checked regularly by trypan blue
taining. All the above experiments were done in duplicates and
erformed at least thrice under the same conditions.
aising M.  agalactiae antiserum
M.  agalactiae speciﬁc antiserum was generated in rabbits as
escribed earlier (Ruhnke and Rosendal, 1994) by subcutaneous
noculation of 1010 cfu of M.  agalactiae type strain PG2 at the Insti-
ute of Bacteriology, Mycology and Hygiene, Veterinary Medicine
niversity of Vienna, Austria.
ouble immunoﬂuorescence assay
Double immunoﬂuorescence assay was performed to visually
etect M.  agalactiae inside the eukaryotic cells. The assay was  per-
ormed as originally described (Heesemann and Laufs, 1985) and
reviously applied on mycoplasmas (Winner et al., 2000) with
inor modiﬁcations. Eukaryotic cells were seeded on eight-well
ab-Tek II Chamber Slides (Nalge Nunc International, Naperville, IL)
n their respective media and conﬂuent monolayers were infected
ith mycoplasmas at a MOI  of approximately 20 as described above
nd incubated at 37 ◦C with 5% CO2 for 24 h for optimal invasion.
nbound bacteria were washed away with PBS containing 2% BSA
nd chamber slides overlaid with 300 l of 1:200 diluted rabbit
nti-M. agalactiae serum and gently shaken for 30 min  at room tem-
erature. After washing away the excessive antiserum, the cells
ere covered with ﬂuorescein isothiocyanate (FITC)-labeled goat
nti-rabbit immunoglobulin G (IgG) (Invitrogen) as a secondary
ntibody for 20 min  at room temperature with shaking to stain
xtracellular mycoplasmas. After air-drying, cells were permeabil-
zed for antibody diffusion by successively treating with 50%, 70%,
nd 96% (vol/vol) ethanol and twice with 100% methanol for 1 min
ach. The cells were again air-dried prior to treatment with 300 l
f rabbit anti-M. agalactiae serum for 30 min  before labeling with
exas Red-labeled goat antirabbit IgG (Invitrogen) as secondary
ntibody for 20 min  to stain extracellular and intracellular bacte-
ia. After washing, the nuclei were stained with 300 l of 1:2000
iluted DAPI (Invitrogen). After ﬁnal washing, the chambers were
emoved and cells mounted under a glass coverslip in 1:2 (vol/vol)
lycerol-PBS containing 13% (wt/vol) Mowiol (Clariant, Muttenez,
witzerland) and 0.5% (wt/vol) n-propyl gallate (Sigma). The cells
ere examined under OLYMPUS AX 70 epiﬂuorescence microscope
ith an oil immersion lens (magniﬁcation, ×100). Extracellular
ycoplasmas were observed as green spots using FITC ﬁlter set,
hereas the Texas Red ﬁltering revealed both the extracellularal Microbiology 304 (2014) 1024–1031
and intracellular mycoplasmas as red spots. The two images were
superimposed using the Soft Imaging System Cell* from Olympus,
Muenster, Germany, whereby intracellular mycoplasmas appeared
red and extracellular mycoplasmas appeared yellow due to the
overlap of red and green color.
Systemic spread and reisolation of M.  agalactiae from different
inner organs of experimentally infected sheep
Clinically healthy lactating ewes of the local mountain breed,
negative for major sheep pathogens (attested by routine bacterio-
logical and PCR diagnostics) and also conﬁrmed to be seronegative
for M. agalactiae by two  different commercial ELISA kits (Cypress
Diagnostics, Langdorp, Belgium and IDEXX Montpellier SAS,
Montpellier, France) were infected via the right teat canal as
described earlier (Chopra-Dewasthaly et al., 2012). The inoculum,
which consisted of 109 bacteria/sheep in 5 ml  volume, was pre-
pared as described before (Chopra-Dewasthaly et al., 2012) except
that the pellet was  resuspended in PBS (Gibco BRL, Life Technolo-
gies). The sheep were housed at the Veterinary Medicine University
of Vienna, Austria, and infections carried out in accordance with
the guidelines of the Austrian law for animal protection with the
requisite ofﬁcial approval. Sheep were subjected to regular clini-
cal and serological examination 1 week prior to the intramammary
infection and during the entire experimental period of 2 weeks.
Presence of bacteria in milk and in mucosa of eye, ear, nose, and
genitals was  checked regularly by culturing in Aluotto medium
as described earlier (Chopra-Dewasthaly et al., 2012). The animals
were humanely killed after a fortnight and various organs, such as
spleen, lungs, kidneys, udders, heart, brain, uterus, liver and joint
tissue, and also various lymph nodes including mandibular, parotid,
medial and lateral retropharyngeal, superﬁcial cervical, mediasti-
nal, jejunal, mesenterial, medial iliac, popliteal and supramammary
were obtained. A portion of each of these was  immediately cultured
and the rest of the samples stored at −80 ◦C in individual sterile
vials for subsequent examination. Bacteria from these necropsied
specimens were isolated by growing undiluted and diluted tissue
samples in Aluotto medium at 37 ◦C for 7 days. Conﬁrmation of
M. agalactiae was  made by standard biochemical and serological
methods as described earlier (Chopra-Dewasthaly et al., 2012) and
by performing M. agalactaie speciﬁc PCR based on 16S rRNA gene
(Chavez Gonzalez et al., 1995). Host tissues found positive for M.
agalactiae were cultured again in SP4 medium (Chopra-Dewasthaly
et al., 2005b) for calculating quantitative mycoplasma loads per
gram of tissue by excising, weighing and inoculating an estimated
small part (about 1 cm3) from the frozen −80 ◦C sample (Chopra-
Dewasthaly et al., 2012).
In vivo detection of M.  agalactiae by immunohistochemical
analysis
Tissue samples collected from necropsied animals were ﬁxed
in 10% buffered formalin, alcohol dehydrated, embedded in paraf-
ﬁn wax and stained with haematoxylin-eosin and examined by
light microscopy. Additional sections were stained for demonstra-
tion of mycoplasmas using a rabbit polyclonal antiserum raised
against whole cell antigens of M. agalactiae (as described above
in Section 2.4). Immunohistochemistry was  performed using the
HRP polymer method on a Lab Vision-Autostainer (Thermo Fisher
Scientiﬁc, Fremont, CA). Brieﬂy, the parafﬁn wax  sections (2 m)
were mounted on positively charged glass slides (Superfrost plus;
Menzel Glaeser, Braunschweig, Germany) and deparafﬁnized with
Neo Clear® solution (Merck, Darmstadt, Germany) and rehydrated
twice in 100% alcohol and once in 96% and 70% alcohol and ﬁnally
in distilled water. Antigen retrieval was performed by heating the
slides in citrate buffer (pH 6.0) in the Lab Vision PT Module (Thermo
Medic
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isher Scientiﬁc). To reduce nonspeciﬁc background staining due to
ndogenous peroxidase, slides were incubated in Hydrogen Per-
xidase Block (Thermo Fisher Scientiﬁc) for 5 min, followed by
 10-min incubation in Ultravision Protein Block (Thermo Fisher
cientiﬁc). Subsequently, the sections were incubated with the pri-
ary antibody (rabbit anti – M.  agalactiae serum 1:1500) for 30 min
t room temperature, followed by the Primary Antibody Enhancer
Thermo Fisher Scientiﬁc) for 15 min, and ﬁnally with Large Volume
RP Polymer (Thermo Fisher Scientiﬁc) for 20 min. Large Volume
AB Plus Substrate System (Thermo Fisher Scientiﬁc) was  used
s chromogen for 5 min. After counterstaining with 1:8 diluted
ayer’s Hematoxylin (Thermo Fisher Scientiﬁc) for 1 min, the sec-
ions were dehydrated in alcohols (70, 96, and 100%) and treated
ith Neo Clear® (Merck, Darmstadt, Germany) before mounting
hem in Neomount (Merck, Darmstadt, Germany) for microscopic
xamination.
tatistical analysis
Invasion rates are expressed as mean ± standard deviation (SD)
f n independent values. The signiﬁcance of differences between
eans of experiments was calculated by Student’s t test using
raphPad Prism 5 (Graphpad Software Inc, CA, USA). Differences
ith P < 0.05 were considered signiﬁcant.
ig. 1. Double immunoﬂuorescence staining showing the invasion of M. agalactiae into 
he  infected monolayer. FITC ﬂuorescence showing extracellular mycoplasmas stained gr
tained  red, and DAPI ﬂuorescence showing cell nuclei stained blue. Merged images indic
ars,  10 m.al Microbiology 304 (2014) 1024–1031 1027
Results
Entry of M. agalactiae into mammalian cells
The ability of M. agalactiae to invade mammalian cells was inves-
tigated by infecting three different mammalian cell lines with the
pathogenic type strain PG2. Apart from HeLa, which is a standard
epithelial cell line used in many mycoplasma invasion studies
(Andreev et al., 1995; Winner et al., 2000; Yavlovich et al., 2004;
Marques et al., 2010; Fürnkranz et al., 2013; Hopfe et al., 2013),
gentamicin invasion assays were also performed on cultured rumi-
nant cells, namely BEND and BLF. PG2 cells were incubated with
these mammalian cells at an MOI  of 10–30 for 4, 8, 16 and 24 h
before subjecting them to gentamicin treatment to kill extracellu-
lar bacteria and then directly plated onto SP4 agar to enumerate
viable intracellular bacteria by cfu counts. Each cfu represents an
infected eukaryotic cell and might be actually corresponding to
more than one mycoplasma cell residing in the same eukaryotic
host cell. This implies that the actual invasion frequency might
be higher than the calculated value as most infected cells were
observed to harbor multiple mycoplasma cells in them (Fig. 1).
The invasion frequency was expressed as percentage ratio of num-
ber of recovered intracellular bacteria to the number of bacteria
used for the initial infection. For HeLa cells an increase in invasion
frequencies was  observed with increasing infection times (Fig. 2).
HeLa-229 and BEND and BLF cells. The ﬁve panels correspond to the same area of
een, Texas Red ﬂuorescence showing extracellular and intracellular mycoplasmas
ating the localization of extracellular (yellow) and intracellular (red) mycoplasmas.
1028 S. Hegde et al. / International Journal of Medical Microbiology 304 (2014) 1024–1031
Fig. 2. Invasion of M. agalactiae type strain PG2 into cultured HeLa-229 cells at dif-
ferent times post infection. The percentage invasion was  calculated by dividing the
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Fig. 3. Fate of M. agalactiae after entry into the eukaryotic cells. HeLa-229 cells were
incubated with M.  agalactiae type strain PG2 for 24 h followed by gentamicin treat-
ment for 3 h at 37 ◦C. Cells were washed and incubated with fresh MEM  with (blackfu  value obtained after gentamicin treatment with the cfu value of total mycoplas-
as  added for infection and multiplied by 100. The data represent mean (±SD) of
our independent experiments performed in duplicate.
he invasion at 4 h post infection was quite low (0.032% ± 0.01)
nd thereafter increased exponentially with highest rates wit-
essed at 24 h post infection (2.28% ± 0.19). Such long infection
eriods and/or comparable invasion frequencies have earlier been
eported for many bacterial pathogens, including mycoplasmas,
hich were predominantly known to be extracellular but were sub-
equently shown to have alternative intracellular lifestyle (Martin
nd Mohr, 2000; Dusanic et al., 2009; Marques et al., 2010; Buim
t al., 2011; Hopfe et al., 2013; Lamberti et al., 2013). The per-
entage invasion frequency differed slightly for the three cell
ypes. At 24 h post infection, the invasion frequency for BEND
ells (2.14% ± 0.8) was comparable to HeLa but BLF cells demon-
trated a relatively lower frequency of 1.14 ± 0.5. It was checked
hat incubation of mycoplasmas in MEM  medium alone for this
ime period of 24 h yielded negligible or no increase in their num-
ers.
Invasion of M.  agalactiae into non-phagocytic cells was fur-
her conﬁrmed by double immunoﬂuorescence staining as used
or other mycoplasmas (Winner et al., 2000) with some modiﬁca-
ions as mentioned above under Section 2.6. Since the gentamicin
nvasion assay had indicated optimal invasion rates at 24 h post
nfection, this time point was selected for ﬂuorescence stain-
ng to enable proper readouts. The results clearly demonstrate
he intracellular status of M.  agalactiae as seen in Fig. 1, which
hows ﬁve micrographs, each corresponding to the same area
f infected HeLa, BEND and BLF cells. Extracellular mycoplasmas
ere observed as green spots using FITC ﬁlter set, whereas the
exas Red ﬁltering revealed both the extracellular and intracellular
ycoplasmas as red spots. The two images were superimposed and
ntracellular mycoplasmas appeared red. As controls, uninfected
ukaryotic monolayers were also stained to rule out the possibility
f any previous contamination with mycoplasmas and/or any cross-
eactivity of antibodies. In agreement with the gentamicin invasion
ssay results, BLF cells showed comparatively fewer intracellu-
ar mycoplasmas via double immunoﬂuorescence as compared to
END and HeLa cells (Fig. 1).
ate of M.  agalactiae after entry into the eukaryotic cells
Cell invasion and subsequent intracellular survival, intermit-
ent or prolonged, is an important strategy of many successful
athogens to evade the host immune response. Not just the entry
ut also the exit from the host cell is a critical step for an intracel-
ular pathogen (Hybiske and Stephens, 2007, 2008; Friedrich et al.,
012; Lamberti et al., 2013). Therefore, fate of M.  agalactiae was
valuated after its entry into HeLa cells. This was done by infect-
ng HeLa cells with M.  agalactiae for 24 h and further treating themsquares) or without (black circles) gentamicin for additional 8, 16 and 24 h, and then
trypsinized and plated to enumerate the viable mycoplasmas. Mean values ± SD
from three independent experiments performed in duplicate are indicated.
with gentamicin to kill extracellular bacteria. This was followed
by additional incubations for 8, 16, or 24 h in absence, as well as in
presence of gentamicin at a concentration of 50 g/ml. Viable intra-
cellular bacteria were enumerated at these different times by cfu
counts as described in Section 2.3. The results, as shown in Fig. 3,
are very different for the cells incubated in presence of gentam-
icin as compared to those that were incubated in absence of the
same. In presence of gentamicin, a continuous decrease in the cfu
counts is observed until the last tested time point of 24 h of incu-
bation. Compared to this, in absence of gentamicin the cfu count
is not going down and rather shows an increase by 24 h of incu-
bation. Two possibilities could explain the latter results whereby
the bacteria are either replicating extracellularly or intracellularly.
But intracellular multiplication is ruled out as parallel incuba-
tions in gentamicin show a continuous decrease in the cfu counts.
Taken together, these results imply that intracellular M.  agalactiae
is released in a viable state into the surrounding medium and possi-
bly multiplies extracellularly to reinfect new host cells, as observed
in case of incubation in the absence of gentamicin. Since we  did not
see any cell death in parallel uninfected wells during 24 h infec-
tion, the exit of M. agalactiae is likely not due to cell lysis caused
by culture overgrowth. As a control, presence of gentamicin was
checked to have no adverse effects on the viability of eukaryotic
cells.
In vivo systemic dissemination of M. agalactiae to distant body
sites during experimental intramammary sheep infection
M. agalactiae causes chronic and persistent infections in small
ruminants and the infected animals continue to shed the bacteria
for several months, sometimes for several years (Bergonier et al.,
1997; Gomez-Martin et al., 2013). Cell invasion is believed to play
a major role in the systemic spreading of many pathogens, includ-
ing mycoplasmas (Cieri et al., 2002; Much et al., 2002). Apart from
a report describing the isolation of M. agalactiae from naturally
infected goats (Gomez-Martin et al., 2012) there are hardly any
such reports based on experimental infections of lactating sheep.
However, sporadic isolation of M. agalactiae (P89) was observed in
spleen and lungs of very few lambs experimentally infected via the
conjunctival route (Sanchis et al., 1998). We  wanted to formally
address the ability of M. agalactiae to cross the epithelial barrier of
the udder and disseminate throughout the body by demonstrating
its isolation from various internal organs during an experimental
intramammary sheep infection. Routine milk and mucosal swab
samples, as well as the necropsied tissue and lymph node samples
were checked for the reisolation of M. agalactiae via culture and PCR
methods as described earlier (Chavez Gonzalez et al., 1995; Chopra-
Dewasthaly et al., 2012). Data demonstrated the presence of
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Fig. 4. Immunohistochemical detection of M. agalactiae in samples obtained from sheep experimentally infected via the intramammary route and necropsied at Day  16 p.i.
M.  agalactiae speciﬁc signals are observed in spleen (A), lung (B), choroid plexus of brain (C), udder (D) and, left (E) and right (F) popliteal lymph nodes respectively, using
a 0.
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onti-M.  agalactiae speciﬁc rabbit polyclonal antibodies. (A)–(D), ×40; (E) and (F), ×2
.  agalactaie in various internal organs collected from infected ani-
als (Table 1). Apart from the expected organs such as udders and
ymph nodes, M.  agalactiae was also detected in liver, lungs, uterus,
idneys, heart, brain, and carpal and knee joint tissues (Fig. 4). The
esults clearly illustrate the successful dissemination and bilateral
preading of the pathogen from the single site of infection, that is,
he right teat canal, to several distant body sites, including heart and
rain (see Table 1). Quantitative mycoplasma loads in organs, such
s uterus, udder, popliteal lymph nodes and lungs varied between
03 and 105 cfu/g of tissue (Table 2). All samples found positive
n M.  agalactiae speciﬁc PCR did not show mycoplasma loads dur-
ng quantitative analysis. This might be due to the already low
ycoplasma count in these samples that die further during the sen-itive freeze/thaw cycles needed for cfu enumeration. Overall, the
esults show for the ﬁrst time the systemic spread of M. agalactiae to
ew anatomic sites during experimental intramammary infection
f sheep.Immunohistochemical demonstration of M. agalactiae’s cell
invasiveness during an in vivo infection
Detection of M. agalactiae in ovine mastitis by immunohisto-
chemistry has not been reported so far. Various tissue samples
obtained at necropsy were examined by immunohistochemistry
using PG2 speciﬁc polyclonal antiserum to determine the presence
of M. agalactiae in tissue/organs of infected animals. As illustrated
in Fig. 4D, M. agalactiae antigens were clearly visible in the cyto-
plasm of mammary duct epithelium. Not only in the expected
udder tissue, but also for the ﬁrst time, M. agalactae was detected
in the distant internal organs, such as the lungs (Fig. 4B), brain
(Fig. 4C) and spleen (Fig. 4A) of experimentally infected sheep
using immunohistochemistry technique. Interestingly, immuno-
histochemical staining of the lung (Fig. 4B) and brain tissue (Fig. 4C)
demonstrated the presence of M. agalactiae in the cytoplasm of
macrophages. Except for spleen, these results are in agreement
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Table 1
Qualitative bacteriological examination of lymph nodes and organs from sheep inoc-
ulated by the intramammary route with 109 viable cfu of M. agalactiae type strain
(PG2) and necropsied at Day 16 p.i.
Organs/Tissue samples PCRa Cultureb Immunohistochemistryc
Supramammary LNd right + + +
Parotid LN right + + NDe
Parotid LN left + + ND
Popliteal LN right + + +
Popliteal LN left + + +
Liver + + −
Udder right + + +
Udder left + + −
Lung left + + +
Lung right + + +
Kidney right + + ND
Spleen − − +
Heart + + −
Uterus (fallopian tube) right + + −
Uterus left + + −
Capsule (carpal joint) left + + ND
Capsule right + + ND
Brain + + +
Synovial ﬂuid (knee joint) right + + ND
a M. agalactiae 16S rRNA speciﬁc PCR results.
b M. agalactiae colonies obtained on Aluotto agar by plating the broth subcultures
of  various tissue and lymph node (LN) samples.
c IHC: immunohistochemical analysis of selected M. agalactiae cultures.
d LN: lymph node.
e ND: not done.
Table 2
Quantitative bacterial examination of lymph nodes and organs from sheep inocu-
lated by the intramammary route with 109 viable cfu of M.  agalactiae type strain
PG2 and necropsied at Day 16 p.i.
Organ/lymph node Mycoplasma loada
Supramammary LNb Right 1.8 × 104
Parotid LN left 5 × 103
Parotid LN right 5 × 103
Uterus (fallopian tube) right 2.46 × 106
Popliteal LN left 5 × 103
Popliteal LN right 5 × 103
Udder right 4.79 × 106
w
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ta Mycoplasma load is represented as cfu/g of tissue/organ/lymph node.
b LN (lymph node).
ith bacterial culture and PCR results, reconﬁrming M. agalactiae’s
apability to spread into anatomically distant body parts during
xperimental infections.
iscussion
Mycoplasmas are generally considered extracellular pathogens
lthough in the last decades there have been quite a few reports
roviding sufﬁcient evidence for some of these species to be capable
f invading eukaryotic host cells (Fürnkranz et al., 2013). How-
ver, for M.  agalactiae,  which is well known for its chronic and
ersistent infections, cell invasion, and for that matter even a pre-
ise or direct account of its cytadherence capability, considering
dherence to be a prerequisite for invasion, is yet to come. This
s in accordance with the fact that it fails to show the more con-
enient phenotypes of hemadsorption and terminal tip structure
nlike some other invasive Mycoplasma spp. (Rosengarten et al.,
000; Winner et al., 2000; Rottem, 2003). The data presented in
his study provides the ﬁrst evidence about the cell invasion capa-
ility of M.  agalactiae pathogenic type strain PG2. Presence of M.
galactiae was demonstrated in the standard HeLa cells, as well as
n two different ruminant cell lines, namely BEND and BLF, using
he quantitative gentamicin invasion assay and the qualitativeal Microbiology 304 (2014) 1024–1031
visual method of double immunoﬂuorescence staining. Though the
highest invasion frequency of M.  agalactiae is calculated to be
around 2.3% at 24 h post infection, it is comparable and even better
than the reported invasion frequencies of some other pathogens,
especially mycoplasmas (Martin and Mohr, 2000; Cieri et al.,
2002; Dusanic et al., 2009; Marques et al., 2010; Buzinhani et al.,
2011)
Furthermore, apart from the in vitro proof of M.  agalactiae cell
invasion, an in vivo experimental infection study was also per-
formed, whereby the pathogen was  demonstrated to be capable
of crossing the epithelial barrier of the infected right udder and
disseminating throughout the body as conﬁrmed by its reisolation
from various internal organs. Cell invasion capacity of pathogens
is often believed to play a signiﬁcant role in their systemic spread
(Winner et al., 2000; Cieri et al., 2002; Much et al., 2002). Whether
M. agalactiae’s modest cell invasiveness actually correlates with the
observed systemic infection needs to be formally demonstrated.
But the fact that M. agalactiae is capable of entering and escaping
cultured eukaryotic cells and its bilateral presence in many differ-
ent host internal organs away from the site of initial in vivo infection
can be well explained, and perhaps indirectly correlated, with its
ability to invade local epithelial cells and/or to spread to draining
lymph nodes before becoming systemic. This is supported by the
immunohistochemical detection of M. agalacatiae in the cytoplasm
of mammary duct epithelium (Fig. 4D) and macrophages present
in different organs (Fig. 4B and C). To our knowledge this is the ﬁrst
study which has formally proved, not only the entry of M.  agalactiae
into host cells, but has also shown using immunohistochemistry
staining, the inter- and intra-cellular residence of this pathogen in
distant internal organs, such as lungs (Fig. 4B), spleen (Fig. 4A), brain
(Fig. 4C), and in the knee and carpal joints (Fig. 4E and F) of sheep
experimentally infected via the right teat canal. Especially inter-
esting is the immunohistochemistry result where M.  agalactiae is
seen in the cytoplasm of macrophages in the lungs (Fig. 4B) and
choroid plexus tissue of the brain (Fig. 4C). This implies that either
the mycoplasma is capable of actively invading these phagocytic
cells, or it has partially or fully survived the macrophage phagocy-
tosis and subsequent immune clearance at the time of necropsy.
Both possibilities are equally intriguing and would provide a fresh
insight into the pathogenicity mechanisms of M.  agalactiae.
An important ﬁnding of the present study is that the internalized
M. agalactiae is released into the extracellular media in a perfectly
viable state, though it is difﬁcult to conclude anything about its
intracellular replication under the given experimental conditions.
After exiting the host cells, mycoplasmas tend to multiply and rein-
fect new host cells. This in vitro scenario could very well reﬂect
the sequence of events occurring in vivo during the experimen-
tal intramammary infection, where the bacteria is speculated to
have translocated through various host cell layers by cell inva-
sion, exit and reinfection, thereby leading to the systemic spread of
infection.
As for most other invasive mycoplasmas, the precise mecha-
nism employed by M. agalactiae to enter non-phagocytic host cells
is unknown. It is likely that surface proteins facilitating adhesion
will have an effect on invasion, though adherence is not sufﬁ-
cient to trigger invasion events. M. agalactiae lacks a dedicated
terminal tip structure where adhesion related molecules are local-
ized for efﬁcient cytadherence of some important mycoplasma
pathogens (Rottem, 2003). Except for P40 (Fleury et al., 2002), no
other cytadhesin has been identiﬁed in M. agalactiae,  although the
Vpma family of variable surface lipoproteins were shown to con-
tain adhesion epitopes found in the homologous Vsp proteins of M.
bovis (Glew et al., 2002), a close phylogenetic relative of M.  agalac-
tiae (Askaa and Ernø, 1976). Further investigations into the detailed
invasion mechanisms of M. agalactiae,  including the identiﬁcation
of mycoplasma adhesins and invasins and also eukaryotic host
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eceptors will add to our understanding of this important ruminant
athogen.
It is thus clear that like many other bacterial pathogens, the
ivision between intracellular and extracellular mycoplasmas is
ecoming increasingly blurred as more and more pathogens origi-
ally believed to be extracellular are now shown to have alternative
ntracellular lifestyles (Bower et al., 2005; Fürnkranz et al., 2013;
amberti et al., 2013). This alternative capacity of M. agalactiae,  even
f it is exhibited by a very small subpopulation of total infected cells,
ight provide the pathogen with a gross advantage at the popula-
ion level to hide from antibiotics and host immune responses and
o navigate through the host body to reestablish infection in new
ost niches, thus causing persistent infections that are difﬁcult to
radicate.
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